Rastogi, A.; Qiu, R.; Campoli, R.; Altayeh, U.; Arriaga, S.; Khan, M.J.; Saravanaguru Vasanthi, S.; Hillwig, R.; Puri, N.
The Role of Fat Mass and Obesity-Associated (FTO) Gene in Non-Small Cell Lung Cancer Tumorigenicity and EGFR Tyrosine Kinase Inhibitor Resistance. Biomedicines 2025, 13, 1653.
https://doi.org/10.3390/biomedicines13071653
AMA Style
Rastogi A, Qiu R, Campoli R, Altayeh U, Arriaga S, Khan MJ, Saravanaguru Vasanthi S, Hillwig R, Puri N.
The Role of Fat Mass and Obesity-Associated (FTO) Gene in Non-Small Cell Lung Cancer Tumorigenicity and EGFR Tyrosine Kinase Inhibitor Resistance. Biomedicines. 2025; 13(7):1653.
https://doi.org/10.3390/biomedicines13071653
Chicago/Turabian Style
Rastogi, Aayush, Rong Qiu, Rachel Campoli, Usama Altayeh, Sarai Arriaga, Muhammad J. Khan, Subaranjana Saravanaguru Vasanthi, Robert Hillwig, and Neelu Puri.
2025. "The Role of Fat Mass and Obesity-Associated (FTO) Gene in Non-Small Cell Lung Cancer Tumorigenicity and EGFR Tyrosine Kinase Inhibitor Resistance" Biomedicines 13, no. 7: 1653.
https://doi.org/10.3390/biomedicines13071653
APA Style
Rastogi, A., Qiu, R., Campoli, R., Altayeh, U., Arriaga, S., Khan, M. J., Saravanaguru Vasanthi, S., Hillwig, R., & Puri, N.
(2025). The Role of Fat Mass and Obesity-Associated (FTO) Gene in Non-Small Cell Lung Cancer Tumorigenicity and EGFR Tyrosine Kinase Inhibitor Resistance. Biomedicines, 13(7), 1653.
https://doi.org/10.3390/biomedicines13071653
